Trial intelligence / Profile preview

Synbiotic Tablet Usage in Smokers and Nonsmokers With Gingivitis

NCT03455192Completed

Sponsor
Kırıkkale University
Start
Jul 2014
Primary completion
Jun 2015
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Kırıkkale University. Primary endpoints: Interleukin-6 level of Gingival Crevicular Fluid at 2 months, Interleukin-8 level of Gingival Crevicular Fluid at 2 months and 1 more. Started Jul 2014; status: completed.

Beyond the preview

Go deeper on NCT03455192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03455192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call